ALX ONCOLOGY HOLDINGS INC

For the period ended Jun 30, 2024. Filed Aug 12, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 12, 2024

ALXO$1.29+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	June 30,	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$15,534	$22,406
Short-term investments	141,189	160,330
Prepaid expenses and other current assets	11,989	5,923
Total current assets	168,712	188,659
Property and equipment, net	3,316	3,589
Long-term investments	29,475	35,411
Other assets	13,115	14,894
Total assets	$214,618	$242,553
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$8,146	$8,591
Payable and accrued liabilities due to related party	226	543
Accrued expenses and other current liabilities	30,077	26,867
Total current liabilities	38,449	36,001
Term loan, non-current	9,769	9,639
Other non-current liabilities	7,083	7,201
Total liabilities	55,301	52,841
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 52,452,749 and 49,951,989 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	52	50
Additional paid-in capital	720,590	675,678
Accumulated other comprehensive income (loss)	(73)	256
Accumulated deficit	(561,252)	(486,272)
Total stockholders’ equity	159,317	189,712
Total liabilities and stockholders’ equity	$214,618	$242,553

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.